100
Participants
Start Date
October 31, 2006
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
modified release formulation of oxcarbazepine (OXC MR)
Patients who are pre-treated with a total daily dose of exactly 900 or exactly 1200 mg or exactly 1500 mg oxcarbazepine (as OXC IR) will increase dosage of OXC by 300 mg to a daily dose of 1200 mg / 1500 mg / 1800 mg OXC MR. Dosage will be titrated to a maximum tolerated total daily dose, maximally to 2700 mg in steps of 300 mg every 6th day.
immediate release formulation of oxcarbazepine (OXC IR)
Patients who are pre-treated with a total daily dose of exactly 900 or exactly 1200 mg or exactly 1500 mg oxcarbazepine (as OXC IR) will increase dosage of OXC by 300 mg to a daily dose of 1200 mg / 1500 mg / 1800 mg OXC IR (divided in two daily doses). Dosage will be titrated to a maximum tolerated total daily dose, maximally to 2700 mg in steps of 300 mg every 6th day.
Bergisch Gladbach
Bonn
Erlangen
Freiburg im Breisgau
Göttingen
Kehl-Kork
Lead Sponsor
Collaborators (1)
FGK Clinical Research GmbH
INDUSTRY
Desitin Arzneimittel GmbH
INDUSTRY